Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $345,460 | 204 | 65.0% |
| Travel and Lodging | $101,580 | 384 | 19.1% |
| Consulting Fee | $55,825 | 21 | 10.5% |
| Food and Beverage | $27,218 | 620 | 5.1% |
| Gift | $1,414 | 2 | 0.3% |
| Education | $351.63 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $204,260 | 288 | $0 (2024) |
| ABBVIE INC. | $201,045 | 543 | $0 (2024) |
| ITI, Inc. | $59,989 | 122 | $0 (2023) |
| USWM, LLC | $34,836 | 100 | $0 (2023) |
| Allergan, Inc. | $8,996 | 13 | $0 (2021) |
| Biogen, Inc. | $7,061 | 9 | $0 (2024) |
| Corium, LLC | $5,730 | 37 | $0 (2024) |
| Alkermes, Inc. | $3,686 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,100 | 1 | $0 (2021) |
| Axsome Therapeutics, Inc. | $899.14 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,554 | 112 | ABBVIE INC. ($1,154) |
| 2023 | $54,708 | 165 | Teva Pharmaceuticals USA, Inc. ($37,764) |
| 2022 | $258,317 | 534 | ABBVIE INC. ($127,319) |
| 2021 | $214,269 | 430 | AbbVie Inc. ($72,141) |
All Payment Transactions
1,241 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $78.53 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/09/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $109.08 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Central Nervous System | ||||||
| 11/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $74.86 | General |
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $43.91 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $103.02 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $71.82 | General |
| Category: Neurology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $102.25 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $6.06 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/28/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $106.30 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $94.20 | General |
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $114.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Neurology | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $7.93 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Neurology | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 262 | 628 | $102,940 | $23,009 |
| 2021 | 7 | 310 | 696 | $128,280 | $25,954 |
| 2020 | 9 | 472 | 1,225 | $259,920 | $52,785 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 66 | $17,810 | $4,261 | 23.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 39 | 96 | $18,900 | $3,704 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 37 | $11,790 | $3,279 | 27.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 52 | 148 | $11,100 | $2,972 | 26.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 17 | 77 | $9,856 | $2,593 | 26.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 17 | 77 | $9,856 | $2,362 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 48 | $9,570 | $2,052 | 21.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $5,280 | $1,181 | 22.4% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2022 | 23 | 47 | $7,980 | $400.60 | 5.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 21 | 21 | $798.00 | $204.68 | 25.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 71 | 182 | $37,305 | $6,927 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 99 | $26,650 | $5,823 | 21.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 81 | 231 | $17,325 | $4,543 | 26.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 88 | $17,480 | $3,150 | 18.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 23 | $11,160 | $2,676 | 24.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 25 | $8,040 | $2,444 | 30.4% |
| 90785 | Interactive complexity | Office | 2021 | 26 | 48 | $10,320 | $389.88 | 3.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 273 | $74,760 | $13,739 | 18.4% |
| 90847 | Family psychotherapy including patient, 50 minutes | Office | 2020 | 52 | 148 | $37,000 | $10,253 | 27.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 82 | 195 | $43,875 | $8,096 | 18.5% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 39 | 125 | $37,500 | $6,848 | 18.3% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 101 | 325 | $24,375 | $6,349 | 26.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 38 | 38 | $16,150 | $3,179 | 19.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 78 | $15,510 | $2,775 | 17.9% |
| 90846 | Family psychotherapy, 50 minutes | Office | 2020 | 14 | 20 | $5,000 | $1,358 | 27.2% |
About Carmen Kosicek, PMHNP-BC
Carmen Kosicek, PMHNP-BC is a Registered Nurse healthcare provider based in Hillsboro, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1255863767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carmen Kosicek, PMHNP-BC has received a total of $531,849 in payments from pharmaceutical and medical device companies, with $4,554 received in 2024. These payments were reported across 1,241 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($345,460).
As a Medicare-enrolled provider, Kosicek has provided services to 1,044 Medicare beneficiaries, totaling 2,549 services with total Medicare billing of $101,748. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Registered Nurse, Registered Nurse
- Location Hillsboro, OR
- Active Since 04/03/2017
- Last Updated 03/11/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1255863767
Products in Payments
- VRAYLAR (Drug) $209,305
- AUSTEDO (Drug) $168,040
- CAPLYTA (Drug) $60,260
- Lucemyra (Drug) $33,153
- Austedo XR (Drug) $17,457
- UZEDY (Drug) $9,819
- Azstarys (Drug) $3,204
- VIVITROL (Drug) $3,052
- AZSTARYS (Drug) $2,162
- ZIMHI (Drug) $1,442
- Auvelity (Drug) $899.14
- Dayvigo (Drug) $552.13
- Dyanavel XR (Drug) $356.42
- UBRELVY (Drug) $344.74
- SPRAVATO (Drug) $311.46
- ARISTADA (Drug) $307.77
- ZURZUVAE (Drug) $301.70
- Adlarity (Drug) $292.79
- LYBALVI (Drug) $200.07
- QULIPTA (Drug) $190.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Hillsboro
Kelli Fuller, Anp-Bc, ANP-BC
Registered Nurse — Payments: $6,682
Shannon Eaton, Msn, Fpmhnp, Pmhnp, MSN, FPMHNP, PMHNP
Registered Nurse — Payments: $1,272
Mrs. Rebeka Calhoun, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $159.98
Mrs. Vicki Grossman, Rn Msn Aprn, RN MSN APRN
Registered Nurse — Payments: $61.66
Robyn Pham
Registered Nurse — Payments: $15.75
Mrs. Patty Day, Rn, Msn, Cnp, RN, MSN, CNP
Registered Nurse — Payments: $14.17